MedPath
TGA Approval

SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system (375976)

375976

SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system

AbbVie Pty Ltd

October 4, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01703-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01702-1

Active Ingredients

Risankizumab

© Copyright 2025. All Rights Reserved by MedPath